An expert panel voted overwhelmingly to put restrictions and limitations on testosterone booster use. The panel suggests the U.S. Food and Drug Administration created standards to ensure that testosterone boosters, or Low T drugs, are not being given to men who merely present common signs of aging, such as low libido and fatigue.
The panel, comprised of 20 healthcare experts, voted 19-1 in favor of strict new limitations on testosterone boosters. Some doctors worry the limitations might not be enough, however, as label warning and limitations do not necessarily prohibit a doctor from prescribing testosterone boosters to patients.
The multi-billion dollar testosterone industry has skyrocketed over the past decade, thanks in part to “testosterone clinics,” which often prescribe boosters without conducting necessary tastes to determine testosterone deficiency, or “hypogonadism.” Many patients may be at an increased risk of testosterone booster side effects, including heart attacks and stroke.